TTAM NYSE Week ended 31 Jul 2026

Weekly Investor Report

Titan America SA · Basic Materials · Building Materials

Open interactive chart View report data
Latest close 15.48 USD
-9.7% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -7.7% below the Trend Line and sits at 30.5% of its 52-week range. The latest completed week returned -9.7%, after a -15.0% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bearish with 62/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: earnings are due in 2d.

Setup score 35 out of 100
Latest Close 15.48 USD 31 Jul 2026
1W Return -9.7% latest completed week
4W Return -15.0% short-term follow-through
12W Return -6.1% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • 2 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -9.7% Latest completed week; four-week move -15.0%. Indicator stack 31/47 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 62/100 conviction; expected move 9.9%. News sentiment 53/100 50 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -7.7% below the Trend Line and sits at 30.5% of its 52-week range. The latest completed week returned -9.7%, after a -15.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4812-week average 0.34

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.48Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -15.0% over four weeks, -6.1% over 12 weeks, and 13.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-9.7%
4W-15.0%
12W-6.1%
26W-10.4%
52W13.3%
Active trend streak0 weeks
Active weeks in one year29
Trend breadth55.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.17Latest activity-pressure read.
Pressure change-80.3%Four-week change in activity pressure.
Leadership-12.23Latest relative-leadership reading.
RS change-444.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength92/100Blend of value, momentum, and quality. Underlying universe rank 9; rank 1 is best.
Value77/100Relative valuation strength. Underlying universe rank 24; rank 1 is best.
Quality87/100Profitability and accounting quality. Underlying universe rank 14; rank 1 is best.
Momentum74/100Medium-term price momentum. Underlying universe rank 27; rank 1 is best.
Growth26/100Revenue and earnings growth. Underlying universe rank 75; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework71/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
17.1x
Price divided by trailing earnings.
Price / sales
1.9x
Market value relative to trailing revenue.
EV / EBITDA
8.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
14.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
26.1%
Gross profit retained from each unit of revenue.
Operating margin
16.0%
Operating profit retained from revenue.
Free-cash-flow margin
28.3%
Free cash flow generated from revenue.
Return on invested capital
15.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.7%
Latest one-year revenue growth.
EPS growth
8.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
23.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.9%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

TTAM shows bearish options pressure with a 62/100 conviction score, put-call volume ratio of n/a, expected move of 9.9%, and Sharemaestro trend signal inactive.

Conviction62/100
Expected move9.9%
Put/call volume
Pressure-100
Speculation16
Volatility69
Trend agreement36
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 50 relevant articles.

10 positive · 36 neutral · 4 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move9.9%Nearest-chain priced movement where available.
52-week drawdown-20.9%Distance below the 52-week high.
13-week volatility5.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+10.8%Week of 19 Jun.
Worst week-11.4%Week of 6 Mar.
Latest week-9.7%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains5
Flat weeks0
Modest losses7
Sharp losses7
Recent vol5.8%13-week weekly-return volatility.
Base vol4.9%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew4.5% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape37/100

Trend, activity pressure, participation, and risk combine to a 37/100 tape read.

 Indicator analysis30/100

Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 3/12.

Activity pressure 0.48; 2 reversal markers Factors82/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 67; Small Cap Core rank 41 SVQF71/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 299.0 of 1013 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options29/100

TTAM shows bearish options pressure with a 62/100 conviction score, put-call volume ratio of n/a, expected move of 9.9%, and Sharemaestro trend signal inactive.

Bearish · Put-side pressure · Expected move 9.9% Sentiment53/100

Weighted news tone is neutral across 50 relevant articles.

Titan America SA Actuals & Estimates (NYSE:TTAM) Insiders50/100

No recent insider transaction evidence is stored.

 Earnings2d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202615.48 USD-9.7%16.78 USD15.35 USD0.17-12.232.5MOff
24 Jul 202617.15 USD1.2%16.82 USD15.35 USD0.36-1.81870.7KOff
17 Jul 202616.95 USD-2.3%16.81 USD15.33 USD0.68-3.47854.3KOff
10 Jul 202617.35 USD-4.7%16.81 USD15.30 USD0.87-2.69995.3KOff
3 Jul 202618.21 USD-5.7%16.78 USD15.28 USD0.853.551.0MOff
26 Jun 202619.32 USD5.2%16.69 USD15.24 USD0.5812.642.0MOff
19 Jun 202618.37 USD10.8%16.58 USD15.18 USD0.135.001.3MOff
12 Jun 202616.57 USD6.0%16.46 USD15.14 USD-0.30-4.151.5MOff
5 Jun 202615.64 USD-3.7%16.42 USD15.11 USD-0.59-8.981.9MOff
29 May 202616.23 USD7.2%16.42 USD15.11 USD-0.60-8.031.2MOff
22 May 202615.15 USD-3.6%16.36 USD15.09 USD-0.61-13.14884.4KOff
15 May 202615.72 USD-4.7%16.36 USD15.09 USD-0.56-9.331.0MOff
8 May 202616.48 USD-1.6%16.33 USD15.08 USD-0.53-4.881.5MOff
1 May 202616.75 USD2.0%16.27 USD15.06 USD-0.64-1.22907.0KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.